Keywords: s-p, begins, enrollment, heart, bypass, trial, drug
S-P begins enrollment for heart bypass trial
Article | 20 May 2009
US drug major Schering-Plough has started patient enrollment in the Phase III RED-CABG trial for acadesine, an investigational, potentially first-in-class ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
